HGGC and Snapdragon Capital Partners will make a $240 million strategic growth investment in Fullscript, according to a news release.
Fullscript, based in Ottawa, Ontario, describes itself as a supplement dispensing platform and patient adherence tool. Founded in 2011, the company states it generates $300 million in annual revenue.
HGGC, based in Palo Alto, Calif., is a middle-market private equity firm. Founded in 2007, the firm pursues a variety of transactions within several sectors.
Snapdragon, based in Madison, Conn., is a growth-oriented private equity firm focused on health and wellness, consumer services and health services. Founded in 2018, the firm pursues a range of investment types and typically invests between $40 million to $500 million.
Details of the transaction were not disclosed.